Randomised Controlled TrialiVNSn = 235

Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial

Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, Howland R, Kling MA, Rittberg BR, Burke WJ, et al.

Biological Psychiatry · 2005

Key finding

In the pivotal 10-week acute phase trial, active VNS produced a 15.2% response rate versus 10.0% for sham in treatment-resistant depression; the primary endpoint did not reach statistical significance.

Condition
Depression
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
235
View on DOI

Cite this study

Rush, A. J., Marangell, L. B., Sackeim, H. A., George, M. S., Brannan, S. K., Davis, S. M., Howland, R., Kling, M. A., Rittberg, B. R., Burke, W. J., Rapaport, M. H., Zajecka, J., Nierenberg, A. A., Husain, M. M., Ginsberg, D., & Cooke, R. G. (2005). Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biological Psychiatry, 58(5), 347-354. https://doi.org/10.1016/j.biopsych.2005.05.025

Related studies in Depression

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.